(Total Views: 352)
Posted On: 04/30/2020 4:15:31 PM
Post# of 36567
It may be moot, since NGIO is not trading yet, but what is the potential insider ownership for NGIO? Are there more eggs in the NGIO basket? We really don't know.
I continue to believe that Generex needs to consolidate. They have too many irons in the the fire and have not shared the priorities with shareholders. Are we and MSO, R&D company, orthopedic and wound product provider, or something else? We cannot be all of these with such limited funding. We keep asking, "What's the story with the S-1?" "Where's the money?" "Are we doomed to OTC forever, or can we finally return to NASDAQ?"
I continue to believe that Generex needs to consolidate. They have too many irons in the the fire and have not shared the priorities with shareholders. Are we and MSO, R&D company, orthopedic and wound product provider, or something else? We cannot be all of these with such limited funding. We keep asking, "What's the story with the S-1?" "Where's the money?" "Are we doomed to OTC forever, or can we finally return to NASDAQ?"
(2)
(0)
